These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4511281)

  • 1. EEG aspects in the diagnosis and treatment of minimal brain dysfunction.
    Satterfield JH; Lesser LI; Saul RE; Cantwell DP
    Ann N Y Acad Sci; 1973 Feb; 205():274-82. PubMed ID: 4511281
    [No Abstract]   [Full Text] [Related]  

  • 2. EEG issues in children with minimal brain dysfunction.
    Satterfield JH
    Semin Psychiatry; 1973 Feb; 5(1):35-46. PubMed ID: 4803377
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathophysiology of the hyperactive child syndrome.
    Satterfield JH; Cantwell DP; Satterfield BT
    Arch Gen Psychiatry; 1974 Dec; 31(6):839-44. PubMed ID: 4441251
    [No Abstract]   [Full Text] [Related]  

  • 4. EEG Brain Wave Activity at Rest and during Evoked Attention in Children with Attention-Deficit/Hyperactivity Disorder and Effects of Methylphenidate.
    Thomas BL; Viljoen M
    Neuropsychobiology; 2016; 73(1):16-22. PubMed ID: 26812442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [EEG diagnosis before beginning and during drug treatment of hyperkinetic children and adolescents].
    Gabriel KH
    Z Kinder Jugendpsychiatr Psychother; 2003 Aug; 31(3):231-2; author reply 233-4. PubMed ID: 12942795
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychological assessment of children with minimal brain dysfunction.
    Conners CK
    Ann N Y Acad Sci; 1973 Feb; 205():283-302. PubMed ID: 4570234
    [No Abstract]   [Full Text] [Related]  

  • 7. Attention-deficit/hyperactivity disorder: use of cognitive evoked potential (P300) to predict treatment response.
    Sangal RB; Sangal JM
    Clin Neurophysiol; 2006 Sep; 117(9):1996-2006. PubMed ID: 16890481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371].
    Akhondzadeh S; Mohammadi MR; Khademi M
    BMC Psychiatry; 2004 Apr; 4():9. PubMed ID: 15070418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An FMRI auditory oddball study of combined-subtype attention deficit hyperactivity disorder.
    Stevens MC; Pearlson GD; Kiehl KA
    Am J Psychiatry; 2007 Nov; 164(11):1737-49. PubMed ID: 17974940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate and caffeine in the treatment of children with minimal brain dysfunction.
    Garfinkel BD; Webster CD; Sloman L
    Am J Psychiatry; 1975 Jul; 132(7):723-8. PubMed ID: 1094842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of methylphenidate on the power spectrum of ADHD children - an MEG study.
    Wienbruch C; Paul I; Bauer S; Kivelitz H
    BMC Psychiatry; 2005 Jul; 5():29. PubMed ID: 16042816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylphenidate for adolescents with minimal brain dysfunction.
    Mackay MC; Beck L; Taylor R
    N Y State J Med; 1973 Feb; 73(4):550-4. PubMed ID: 4510899
    [No Abstract]   [Full Text] [Related]  

  • 13. An Investigation of Stimulant Effects on the EEG of Children With Attention-Deficit/Hyperactivity Disorder.
    Clarke AR; Barry RJ; Baker IE; McCarthy R; Selikowitz M
    Clin EEG Neurosci; 2017 Jul; 48(4):235-242. PubMed ID: 27552823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age, stimulant drug, and practice effects on P3 latency and concurrent reaction time.
    Halliday R; Callaway E; Lynch M
    Ann N Y Acad Sci; 1984; 425():357-61. PubMed ID: 6588853
    [No Abstract]   [Full Text] [Related]  

  • 15. Introduction: EEG brain waves: a wave of the future or past?
    Arnold LE
    J Atten Disord; 2013 Jul; 17(5):371-3. PubMed ID: 23628967
    [No Abstract]   [Full Text] [Related]  

  • 16. Physiological studies of the hyperkinetic child. I.
    Satterfield JH; Cantwell DP; Lesser LI; Podosin RL
    Am J Psychiatry; 1972 May; 128(11):1418-24. PubMed ID: 4553489
    [No Abstract]   [Full Text] [Related]  

  • 17. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults.
    Wender PH; Reimherr FW; Wood D; Ward M
    Am J Psychiatry; 1985 May; 142(5):547-52. PubMed ID: 3885760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of osmotic-release methylphenidate in attention-deficit/hyperactivity disorder as measured by event-related potentials.
    Sawada M; Iida J; Ota T; Negoro H; Tanaka S; Sadamatsu M; Kishimoto T
    Psychiatry Clin Neurosci; 2010 Oct; 64(5):491-8. PubMed ID: 20923428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer analyzed EEG in methylphenidate-responsive hyperactive children.
    Steinhausen HC; Romahn G; Göbel D
    Neuropediatrics; 1984 Feb; 15(1):28-32. PubMed ID: 6709126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deanol and methylphenidate in minimal brain dysfunction.
    Lewis JA; Young R
    Clin Pharmacol Ther; 1975 May; 17(5):534-40. PubMed ID: 1092513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.